Talphera Stock EBITDA
| TLPH Stock | 0.64 0.02 3.23% |
Talphera fundamentals help investors to digest information that contributes to Talphera's financial success or failures. It also enables traders to predict the movement of Talphera Stock. The fundamental analysis module provides a way to measure Talphera's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Talphera stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -9.8 M | -10.3 M |
Talphera | EBITDA |
Talphera Company EBITDA Analysis
Talphera's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Talphera EBITDA | (9.84 M) |
Most of Talphera's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Talphera is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Talphera EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Talphera is extremely important. It helps to project a fair market value of Talphera Stock properly, considering its historical fundamentals such as EBITDA. Since Talphera's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Talphera's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Talphera's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Talphera Ebitda
Ebitda |
|
According to the company disclosure, Talphera reported earnings before interest,tax, depreciation and amortization of (9.84 Million). This is 101.12% lower than that of the Pharmaceuticals sector and 101.67% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.25% higher than that of the company.
Talphera EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Talphera's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Talphera could also be used in its relative valuation, which is a method of valuing Talphera by comparing valuation metrics of similar companies.Talphera is currently under evaluation in ebitda category among its peers.
Talphera Fundamentals
| Return On Equity | -1.18 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (40.45) % | ||||
| Current Valuation | 4.99 M | ||||
| Shares Outstanding | 16.99 M | ||||
| Shares Owned By Insiders | 1.16 % | ||||
| Shares Owned By Institutions | 30.91 % | ||||
| Number Of Shares Shorted | 41.94 K | ||||
| Price To Book | 1.20 X | ||||
| Price To Sales | 38.43 X | ||||
| Revenue | 651 K | ||||
| EBITDA | (9.84 M) | ||||
| Net Income | (18.4 M) | ||||
| Cash And Equivalents | 90.29 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 6.29 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 0.64 X | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | (17.49 M) | ||||
| Short Ratio | 1.46 X | ||||
| Earnings Per Share | (0.63) X | ||||
| Target Price | 4.17 | ||||
| Number Of Employees | 15 | ||||
| Beta | 0.33 | ||||
| Market Capitalization | 15.29 M | ||||
| Total Asset | 20.39 M | ||||
| Retained Earnings | (444.23 M) | ||||
| Working Capital | 7.04 M | ||||
| Current Asset | 9.04 M | ||||
| Current Liabilities | 14.14 M | ||||
| Net Asset | 20.39 M |
About Talphera Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Talphera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talphera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talphera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Talphera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Talphera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Talphera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Talphera Stock:Check out Talphera Piotroski F Score and Talphera Altman Z Score analysis. For more detail on how to invest in Talphera Stock please use our How to Invest in Talphera guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Revenue Per Share 0.018 | Return On Assets (0.47) | Return On Equity (1.18) |
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Talphera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.